1 Carbimazole was administered to nine hyperthyroid patients, and blood samples were taken at various time intervals for analysis of carbimazole, and its metabolite methimazole. 2 A technique was developed for the measurement of methimazole in serum, using a High-Pressure Liquid Chromatograph, which could detect nanogram quantities of this metabolite.
Introduction

Carbimazole
(1 -carbethoxy-3-methylthioimidazole, Fig. 1 ) was initially synthesized as a potentially long-acting antithyroid drug (Lawson, Rimmington & Searle, 1951) . Although it has not been shown to be significantly longer acting than other antithyroid drugs, e.g. methimazole and propylthiouracil, it is widely used in the treatment of hyperthyroidism.
Plasma concentrations of carbimazole have been difficult to determine, and to date the presence of carbimazole has not been detected in plasma (Marchant, Alexander, Lazarus, Lees & Clark, 1972) . Whilst carbimazole is stable in the solid state or neutral solutions, it is readily hydrolyzed and decarboxylated to methimazole ( Fig. 1) , in alkaline media. In vitro studies with carbimazole in plasma have shown that conversion to methimazole takes place very rapidly (Stenlake, Williams & Skellern, 1970) .
Our attention has been focussed on the examination of methods for studying the pharmacokinetics of carbimazole/methimazole. The gas-liquid chromatographic method developed by Stenlake et al. (1970) for studying the excretion kinetics of methimazole proved to be unsatisfactory for measuring blood levels because of the large volume of plasma required. Spectrofluorimetry based on derivatization with either dichlorobenzoquinocechlorimine (Averbach & Angell, 1958) or dansyl chloride (Chen, 1967) was also unsuccessful. We have found, however, that nanogram quantities of methimazole can be measured in plasma, using High-Pressure Liquid Chromatography (HPLC). This paper reports a study by this HPLC method of the plasma concentration of methimazole from hyperthyroid patients receiving carbimazole.
Methods
Nine female patients attending an outpatient thyroid clinic took part in this study. Details of age, weight and medical history are given in carbimazole. Blood samples were refrigerated until they could be centrifuged to obtain plasma, which was then kept frozen until required for analysis.
Analytical procedure
Extractions. Plasma (1 ml) was diluted with water (3 ml). Methimazole was extracted with chloroform containing 0.5% v/v n-octanol (4 x 10 ml). The extract was transferred to 'evaporating tubes' based on a design of Beckett & Rowland (1965) , and evaporated down to 100,ul using nitrogen.
were made on either of these columns. Calibration curves were obtained by adding appropriate amounts of methimazole (0.3-1.4,ug) to aliquots
(1 ml) of blank plasma. The n-hexane was spectroscopic grade, tetrahydrofuran and chloroform were AnalaR, and the n-octanol of reagent grade.
Hydrolysis of carbimazole. Carbimazole (20 mg) was dissolved in ethanol (5 ml), and made up with water containing concentrated hydrochloric acid (0.6 ml) to 100 ml (pH 1.8). Appropriate dilutions were made so that the extinction at 290 nm could be measured at given time intervals. Similarly, carbimazole was dissolved in phosphate buffer (pH 7.4), containing pooled plasma (10 ml) and the rate of hydrolysis measured. In both cases the hydrolysis mixture was incubated at 370 C. (Fig. 4) , and those whose maximum is reached only after 2 to 3 h ( Figure 5 ). Pittman, Beschi & Smitherman (1971) , found that the maximum for the concentration of methimazole was at 60 min, after Time(h) Table 1 ) after an oral dose of carbimazole (60 mg).
(Methimazole was determined for all patients at the 15, 30 and 60 min time interval).
concentration-time curve was linear after 90 min, and the biological half-life for methimazole was 4 h, 4 h and 3.5 h respectively. There would appear to be some correlation between the serum thyroxine level (Table 1) , and the fact that carbimazole/methimazole is not so extensively metabolized by some patients (Figures  4 and 5 ). The patients with high thyroxine levels tend to have high methimazole concentrations in the blood. This would agree with observations by others, (Kato, Takaraka & Takahashi, 1970) that thyroxine depressed the metabolism of drugs in animals. In particular, Juarez-Peinalva & Mitchell (1964) working with guinea pigs pre-treated with thyroxine showed substantial depression of thyroid uptake and metabolism of [35SI -thiourea. Maloof & Soodak (1965) reported similar findings when working with thyroxine-treated rats; though thyroid uptake was more markedly depressed than metabolism. Due to the small number of patients who took part in this study, we cannot show conclusively a direct correlation. The non-linearity of the calibration curves is a characteristic of plasma protein binding and we have demonstrated that methimazole is appreciably bound to pure human serum albumin and plasma proteins. This is contrary to other reports Sitar & Thornhill, 1973) . Because of interference from protein binding in the assay method, the effect on the linearity of calibration curve of trichloracetic acid, sodium hydroxide and hydrochloric acid, which destroy binding, was examined. None of these reagents was effective and all resulted in a lowering of the recovery of methimazole. Calibration curves were therefore constructed for each patient to overcome any individual idiosyncrasies.
